Apalutamide for treating prostate cancer - A Single Technology Appraisal
Apalutamide for treating prostate cancer - A Single Technology Appraisal
This report is a critique of the company’s submission (CS) to NICE from Janssen-Cilag Ltd on the clinical effectiveness and cost effectiveness of apalutamide (Erleada®) for the treatment of metastatic hormone-sensitive prostate cancer and non-metastatic hormone-relapsed prostate cancer. It identifies the strengths and weakness of the CS.
National Institute for Health and Care Research
Cooper, Keith
ea064f58-d71d-404a-bcf3-49d243b8825b
Tikhonova, Irina
577ccbcc-6643-4190-bb6d-19e13b44bcd1
Woods, Lois
8149aa11-7664-4052-a18b-98f7bde83180
Hazell, Lorna
1c9036d8-13c0-4fe1-88be-9a926dc003b5
Ribeiro, Ines
2fd1901b-61bd-4ad5-81b3-a3f8145ec144
Picot, Joanna
324d6f20-a105-49fd-9fb0-88791be84ada
Scott, David Alexander
19b5fd34-9974-4ae4-8be0-27a693639e20
Shepherd, Jonathan
dfbca97a-9307-4eee-bdf7-e27bcb02bc67
2020
Cooper, Keith
ea064f58-d71d-404a-bcf3-49d243b8825b
Tikhonova, Irina
577ccbcc-6643-4190-bb6d-19e13b44bcd1
Woods, Lois
8149aa11-7664-4052-a18b-98f7bde83180
Hazell, Lorna
1c9036d8-13c0-4fe1-88be-9a926dc003b5
Ribeiro, Ines
2fd1901b-61bd-4ad5-81b3-a3f8145ec144
Picot, Joanna
324d6f20-a105-49fd-9fb0-88791be84ada
Scott, David Alexander
19b5fd34-9974-4ae4-8be0-27a693639e20
Shepherd, Jonathan
dfbca97a-9307-4eee-bdf7-e27bcb02bc67
Cooper, Keith, Tikhonova, Irina, Woods, Lois, Hazell, Lorna, Ribeiro, Ines, Picot, Joanna, Scott, David Alexander and Shepherd, Jonathan
(2020)
Apalutamide for treating prostate cancer - A Single Technology Appraisal
(Health Technology Assessment, HTA - NIHR131879)
National Institute for Health and Care Research
188pp.
Record type:
Monograph
(Project Report)
Abstract
This report is a critique of the company’s submission (CS) to NICE from Janssen-Cilag Ltd on the clinical effectiveness and cost effectiveness of apalutamide (Erleada®) for the treatment of metastatic hormone-sensitive prostate cancer and non-metastatic hormone-relapsed prostate cancer. It identifies the strengths and weakness of the CS.
Text
Apalutamide_ERG_report
- Version of Record
Text
Addendum
- Version of Record
More information
Published date: 2020
Identifiers
Local EPrints ID: 453979
URI: http://eprints.soton.ac.uk/id/eprint/453979
PURE UUID: 2eeca39b-c610-4c24-a1cb-298feb6270db
Catalogue record
Date deposited: 27 Jan 2022 17:30
Last modified: 21 Aug 2024 01:59
Export record
Contributors
Author:
Irina Tikhonova
Author:
David Alexander Scott
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics